HIGHLIGHTS
SUMMARY
*Corresponding Author Issue 1 with the Act, especially for medical information which is categorized under sensitive data will cause serious damages to the data subjects. The evaluation from the perspective of privacy policies will clear that how far the rights of data subjects are being respected by a company while collecting and using their personal data. 35% collect sensitive data, all share the personal data with the third parties and 85% provided for a vague specification of the third parties. The companies must include a clear statement indicating the right of informing individuals upon . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.